Incyte
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
METCALF BRIAN W officer: Chief Drug Discovery S..
 Common Stock 5,000 $3.89 $19,425
Purchase
SWAIN PAULA J officer: EVP, Human Resources
 Common Stock 3,000 $3.65 $10,950
Purchase
HASTINGS DAVID C officer: Chief Financial Officer
 Common Stock 2,500 $3.6 $9,000
Purchase
FRIEDMAN PAUL A director
 Common Stock 5,500 $3.56 $19,580
Purchase
SCHRECK PATRICIA A officer: EVP, General Counsel
 Common Stock 2,000 $3.59 $7,180
Option
FRIEDMAN PAUL A director
 Common Stock 50,000 N/A N/A
Option
FRIEDMAN PAUL A director
 Restricted Stock Units 50,000 N/A N/A
Purchase
FRIEDMAN PAUL A director
 Common Stock 2,700 $7.24 $19,548
Option
FRIEDMAN PAUL A director
 Restricted stock units 50,000 N/A N/A
Option
FRIEDMAN PAUL A director
 Common Stock 50,000 N/A N/A
Option
WHITFIELD ROY A director
 Common stock 50,000 N/A N/A
Option
WHITFIELD ROY A director
 Restricted stock units 50,000 N/A N/A
Purchase
DE SCHUTTER RICHARD U director, other: Chairman
 Common Stock 20,000 $7.05 $140,960
Purchase
BAKER JULIAN director, 10 percent owner
 Common Stock 300,000 $9.75 $2,925,000
Purchase
BROOKE PAUL A director
 Common Stock 100,000 $7.74 $774,000
Purchase
FRIEDMAN PAUL A director
 Common Stock , par value $0.001 per share 3,500 $5.62 $19,653
Purchase
TISCH JAMES S 10 percent owner
 Common Stock 255,750 $5.5 $1,406,625
Purchase
TISCH ANDREW H 10 percent owner
 Common Stock 255,750 $5.5 $1,406,625
Purchase
TISCH DANIEL R 10 percent owner
 Common Stock 255,750 $5.5 $1,406,625
Purchase
TISCH THOMAS J 10 percent owner
 Common Stock 255,750 $5.5 $1,406,625
Option
SAXE JON S director
 Common Stock 20,000 $2.78 $55,620
Option
SAXE JON S director
 Non-Qualified Stock Option (right to buy) 20,000 $2.78 $55,620
Purchase
BAKER BIOTECH CAPITAL II GP LLC 10 percent owner
 Common Stock, par value $0.001 per share ("Common Stock") 70,100 $4.97 $348,537
Purchase
BAKER BROS CAPITAL GP LLC
Common Stock 200 $4.89 $978
Purchase
BAKER BROS CAPITAL GP LLC
Common Stock, par value $0.001 per share("Common Stock") 13,600 $4.97 $67,619
Purchase
BAKER BIOTECH CAPITAL GP LLC
Common Stock 1,000 $4.89 $4,890
Purchase
BAKER BIOTECH CAPITAL GP LLC
Common Stock, par value $0.001 per share ("Common Stock") 66,300 $4.97 $329,644
Purchase
BAKER BIOTECH CAPITAL II GP LLC 10 percent owner
 Common Stock 1,000 $4.89 $4,890
Purchase
BAKER BIOTECH CAPITAL GP LLC
Common Stock, par value $0.001 per share 526,000 $5.04 $2,649,462
Purchase
BAKER BIOTECH CAPITAL II GP LLC 10 percent owner
 Common Stock, par value $0.001 per share 556,350 $5.04 $2,802,335
Purchase
BAKER BROS CAPITAL GP LLC
Common Stock, par value $0.001 per share 107,650 $5.04 $542,233

Showing 1400 to 1431 of 1431 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: